Allergan Inc. voluntarily withdraws its drug Fibristal, used to treat uterine fibroids, from the Canadian market

Product: Fibristal (ulipristal acetate) Issue: Risk of serious liver injury associated with the use of Fibristal What to do: Stop taking Fibristal. Report any signs and symptoms of liver injury such as nausea, vomiting, stomach ache, severe tiredness, yellowing of the eyes or skin, or dark urine to your healthcare provider immediately. Media enquiries Public enquiries